Filling the need for trusted information on national health issues…

Trending on kff Ebola Marketplaces Enrollment

Vaccines

  • your selections
Clear Search

Filter Results

date

Tags

  • results
Early Stage Trial Finds Malaria Vaccine Promotes Immune Response In Young Children, Study Says

An experimental vaccine was found to promote immune responses to malaria in young children in Mali, Reuters reports. According to the news service, “The vaccine, which uses an immune system booster called an adjuvant from British drugmaker GlaxoSmithKline, targets the malaria parasite as it is actively infecting red blood cells and causing fever and illness” (Steenhuysen, 2/3).

Global Cancer Rates Could Be Reduced By 40% With Prevention Strategies, Report Says

“Forty percent of the 12 million people diagnosed with cancer worldwide each year could avert the killer disease by protecting themselves against infections and changing their lifestyles, experts said on Tuesday,” Reuters reports. Ahead of World Cancer Day on Thursday, officials at the International Union Against Cancer (UICC) released a report that demonstrates how scaling up immunization programs against the infections that cause some cancers and educating the public on prevention strategies could help drive down cancer rates (Kelland, 2/2).

Despite Improvements, Aid Delivery Bottlenecks Persist In Haiti

Three weeks after a major earthquake struck Haiti, challenges in getting aid to those in need persist, the Washington Post reports. “Rajiv Shah, the administrator of the U.S. Agency for International Development, said the relief effort has escalated in recent days and will continue to do so. Emergency food aid has been provided to more than a million people in and around Port-au-Prince, but 2 million people are estimated to need such assistance, he said.

New York Times Examines WHO Process For Getting H1N1 Vaccines To Countries In Need

The New York Times examines the WHO’s role as “clearinghouse” for getting H1N1 (swine flu) vaccines to lower income nations. Though H1N1 has died down in North America and many wealthier nations “are trying to get rid of their [vaccine] surpluses,” the virus continues to circulate in regions of North Africa, Central Asia and Eastern Europe, according to the newspaper.

Experimental Vaccine Reduced TB Rate Among HIV-Positive People In Tanzania, Study Finds

An experimental vaccine was found to reduce the rate of tuberculosis infections in patients living with HIV, “the first time a shot has been shown to reduce cases of the most common AIDS-related cause of death in poor nations,” Bloomberg reports (Bennett, 1/29). Tuberculosis accounts for up to one-third of AIDS deaths worldwide, CBC News reports.

Recent Releases In Global Health

Under Shah’s Leadership, USAID Poised ‘To Regain Its Prominence’ In Global Nutrition, Lancet Opinion Says  Rajiv Shah’s appointment as USAID administrator “comes at a crucial time of challenge and opportunity for the Agency to improve the nutritional well-being of impoverished societies,” write the authors of a Lancet Comment that examines…

Canada To Donate 5M Doses Of H1N1 Vaccine To WHO; Agency Has Received Commitment Of 200M Vaccines

The Canadian government on Thursday announced the country would donate five million doses of H1N1 vaccines to the WHO from the country’s current surplus, the Canadian Press reports (Branswell, 1/28). “[T]he donation will help the Geneva-based international body in its efforts to redistribute the vaccine to developing countries that couldn’t afford their own supplies,” the Globe and Mail reports (Alphonso, 1/28).

Rotavirus Vaccine Could Save Millions Of Children In Developing Countries, Studies Find

Over the next decade, efforts to vaccinate “infants against rotavirus could save the lives of millions of children in developing nations who would otherwise die from the diarrhea-causing disease, two new studies show,” HealthDay/BusinsessWeek reports. The studies track diarrhea deaths among children vaccinated against rotavirus in Africa and Mexico and appear in the Jan. 28 issue of the New England Journal of Medicine (Thomas, 1/27).